Table 2.
Neurodegeneration mechanism | 5-HT7 possible role | References |
---|---|---|
Excitotoxicity |
Activation of MAPK/ERK and PI3/Akt/GSK3b protects against glutamate-induced damage Decreased expression of NR2B and NR1 subunits of NMDA glutamate receptors Increased expression of superoxide dismutase and glutathione |
Jiang et al. (2000); Pi et al. (2004); Li et al. (2005) Vasefi et al. (2013a) Yuksel et al. (2019) |
Oxidative stress |
No study evaluated effect in the CNS In a sepsis-induced lung injury, 5-HT7 receptor agonism decreased ROS burden 5-HT7 antagonism decreased oxidative burden in bleomycin-induced pulmonary fibrosis 5-HT7 activation enhances microsome stability towards oxidative metabolism (Lacivita et al., 2016a) ERK and Akt protect PC12 cells from oxidative damage |
Cadirci et al. (2013) Tawfik and Makary (2017) Lacivita et al. (2016a) Ong et al. (2016) |
Apoptosis | 5-HT7 receptor agonism reduces apoptosis in the streptozotocin-induced AD model | Hashemi-Firouzi et al. (2017) |
Long term depression/ potentiation impairment |
5-HT7 KO mice display LTP impairment 5-HT7 agonism reduces mGluR-dependent LTD |
Roberts et al. (2004) Costa et al. (2012) |
Synaptic impairment |
5-HT7 agonism increases dendritic density and synaptogenesis in the cortical and striatal forebrain 5-HT7 agonism induces dendritic sprouting and neurite enlargement |
|
Neurotrophin depletion |
5-HT7 agonism increases PDGF-β 5-HT7 agonism increases the expression and affinity of trk-B |
Vasefi et al. (2013b) Samarajeewa et al. (2014) |